Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-12-033370
Filing Date
2012-05-30
Accepted
2012-05-30 15:31:31
Documents
2
Period of Report
2012-05-29

Document Format Files

Seq Description Document Type Size
1 FORM4-STOCKPURCHASE rrd347160.html 4  
1 FORM4-STOCKPURCHASE rrd347160.xml 4 2950
2 DRUTZ-POA rrd311484_351632.htm EX-24. 5524
  Complete submission text file 0001181431-12-033370.txt   10097
Mailing Address 8601 SIX FORKS ROAD SUITE 160 RALEIGH NC 27615
Business Address 8601 SIX FORKS ROAD SUITE 160 RALEIGH NC 27615 919-861-0202
DARA BioSciences, Inc. (Issuer) CIK: 0000919745 (see all company filings)

EIN.: 043216862 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 8601 SIX FORKS ROAD SUITE 160 RALEIGH NC 27615
Business Address
Drutz David (Reporting) CIK: 0001428764 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23776 | Film No.: 12877389